OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for November, 2014

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2014-11-27 00:15 Medtronic gets U.S. antitrust OK to buy Covidien with divestiture and more... 2014-11-26 12:15 Back for more: Will Pfizer top its AstraZeneca bid? 2014-11-26 00:15 J&J hopes third time is the charm for antitumor agent Yondelis and more... 2014-11-25 12:15 What are the odds? Pfizer-AstraZeneca merger chatter heats up and more... 2014-11-22 12:15 French firm signals 'new era' in malaria fight and more... 2014-11-22 00:15 Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen and more... 2014-11-21 12:15 FDA approval unlikely as PDUFA date approaches for Avanir and more... 2014-11-21 00:15 NewLink in Talks With Merck on Producing Ebola Vaccine and more... 2014-11-20 12:15 Pfizer's MenB reach--and lead on Novartis--limited without ACIP nod and more... 2014-11-20 07:39 Celgene Up on Encouraging Long-Term Phase III Otezla Data and more... 2014-11-19 12:15 Shire relocates 500 jobs to Massachusetts and more... 2014-11-19 00:15 Regeneron drug highly effective for those who can't take statins: study and more... 2014-11-14 12:15 Federal judge has unsealed details in lawsuit filed by the city of Chicago against five makers of opioid painkillers and more... 2014-11-14 00:15 Vascular Solutions and CEO indicted on charges of conspiracy and selling an unapproved device and more... 2014-11-13 12:15 AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods and more... 2014-11-13 00:15 Obesity drug war may be about more than marketing to the overweight and more... 2014-11-12 12:15 TEVA: Copaxone Patent Expiry Worries Are Overblown and more... 2014-11-12 00:15 Major Medical Centers ask Congress to Probe Genentech Distribution Shift and more... 2014-11-11 12:15 Is a Surprise Coming for bluebird bio (BLUE) This Earnings Season? and more... 2014-11-11 00:15 Arrowhead CEO: We feel 'great' about our hepatitis B drug and more... 2014-11-10 12:15 FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab and more... 2014-11-09 12:15 Intercept Pharmaceuticals Below $180: Mega Millions Vanish and more... 2014-11-09 00:15 US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL and more... 2014-11-08 12:15 Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD) and more... 2014-11-08 00:15 Biotech stocks to watch ahead of liver disease conference and more... 2014-11-07 12:15 Gilead Sciences: Another Big Jump in Hep-C Prescriptions and more... 2014-11-07 00:15 Will Pfizer Sweeten Its Bid For AstraZeneca? and more... 2014-11-06 12:15 Oops! Did FDA Mistakenly Give Ranbaxy Approval to Sell Generic Nexium? and more... 2014-11-06 00:15 How Amgen Makes Billions On Just A Few Drugs and more... 2014-11-05 12:15 Glaxo files regulatory submissions for asthma drug candidate and more... 2014-11-05 00:15 Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership and more... 2014-11-04 12:15 Novo Nordisk builds blockbuster case with promising PhIII obesity data and more... 2014-11-04 00:15 Orexigen's Contrave Has Modest Start and more... 2014-11-03 12:15 U.S. Patent Office Significantly Extends the Term of Three RegeneRx Patents and more... 2014-11-02 12:15 Billionaire Carl Berg developing prostate cancer test 2014-11-02 00:15 Doctors refusing to prescribe statins (in the UK) and more... 2014-11-01 00:15 Gilead Sciences: Harvoni Still Selling Like Hotcakes and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe